​

Xencor (XNCR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

XNCR Stock Forecast

Xencor (XNCR) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $27.60, with a high of $42.00 and a low of $18.00. This represents a 67.27% increase from the last price of $16.50.

$15 $21 $27 $33 $39 $45 High: $42 Avg: $27.6 Low: $18 Last Closed Price: $16.5

XNCR Stock Rating

Xencor stock's rating consensus is Buy, based on 27 Wall Street analysts. The breakdown includes 1 Strong Buy (3.70%), 24 Buy (88.89%), 1 Hold (3.70%), 1 Sell (3.70%), and 0 Strong Sell (0.00%).

Buy
Total 27 1 1 24 1 Strong Sell Sell Hold Buy Strong Buy

XNCR Price Target Upside V Benchmarks

TypeNameUpside
StockXencor67.27%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts157
Avg Price Target$29.00$23.60$25.00
Last Closing Price$16.50$16.50$16.50
Upside/Downside75.76%43.03%51.52%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25491--14
Nov, 25481--13
Oct, 25371-112
Sep, 2538--112
Aug, 2538--112
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 24, 2025Truist Financial$29.00$15.8782.73%75.76%
Nov 06, 2025Cantor Fitzgerald$42.00$14.75184.75%154.55%
Oct 29, 2025Etzer DaroutBarclays$23.00$14.2561.40%39.39%
Oct 27, 2025Gregory RenzaRBC Capital$18.00$13.8330.15%9.09%
Sep 16, 2025Barclays$6.00$8.62-30.39%-63.64%
Aug 07, 2025David NierengartenWedbush$26.00$7.32255.19%57.58%
Feb 28, 2025Wedbush$31.00$15.36101.82%87.88%
Dec 02, 2024Edward TenthoffPiper Sandler$30.00$25.6017.19%81.82%
Jun 14, 2024Etzer DaroutBMO Capital$32.00$20.9053.11%93.94%
Jun 14, 2024Gregory RenzaRBC Capital$31.00$20.9947.69%87.88%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 06, 2025Cantor FitzgeraldOverweightOverweighthold
Oct 29, 2025BarclaysOverweightupgrade
Oct 27, 2025RBC CapitalOutperformOutperformhold
Aug 07, 2025WedbushOutperformOutperformhold
Apr 21, 2025William BlairOutperforminitialise
Sep 26, 2024RBC CapitalOutperformOutperformhold
Jun 14, 2024BMO CapitalOutperformOutperformhold
Jun 14, 2024RBC CapitalOutperformOutperformhold
May 10, 2024WedbushBuyBuyhold
Apr 16, 2024WedbushBuyBuyhold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.11$1.42$-0.93$-2.08$-3.58----
Avg Forecast$-1.41$0.24$-1.51$-1.90$-3.66$-3.10$-2.75$-1.58$-2.35
High Forecast$-0.30$0.61$-0.31$0.70$-3.44$-2.79$0.92$0.04$-0.18
Low Forecast$-3.51$0.05$-3.94$-4.56$-3.94$-3.69$-3.70$-2.47$-6.98
Surprise %-21.28%491.67%-38.41%9.47%-2.19%----

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$122.69M$275.11M$164.58M$168.34M-----
Avg Forecast$110.09M$194.55M$164.55M$197.61M$61.23M$113.93M$163.51M$221.98M$236.72M
High Forecast$236.52M$417.96M$368.50M$296.26M$68.72M$178.34M$163.63M$226.27M$594.59M
Low Forecast$43.27M$76.47M$63.59M$106.64M$48.42M$48.25M$163.40M$217.69M$68.43M
Surprise %11.44%41.41%0.02%-14.81%-----

Net Income Forecast

$-500M $-100M $300M $700M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-63.54M$82.63M$-55.18M$-126.09M$-232.62M----
Avg Forecast$-52.28M$1.05B$1.09B$-126.09M$-223.35M$-204.45M$-190.12M$-73.71M$-142.42M
High Forecast$-41.83M$1.27B$1.32B$-98.43M$-208.30M$-168.59M$55.53M$2.19M$-10.80M
Low Forecast$-62.74M$820.13M$851.78M$-153.74M$-238.40M$-223.23M$-224.00M$-149.61M$-422.34M
Surprise %21.53%-92.10%-105.08%-4.15%----

XNCR Forecast FAQ

Is Xencor stock a buy?

Xencor stock has a consensus rating of Buy, based on 27 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Xencor is a favorable investment for most analysts.

What is Xencor's price target?

Xencor's price target, set by 27 Wall Street analysts, averages $27.6 over the next 12 months. The price target range spans from $18 at the low end to $42 at the high end, suggesting a potential 67.27% change from the previous closing price of $16.5.

How does Xencor stock forecast compare to its benchmarks?

Xencor's stock forecast shows a 67.27% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Xencor over the past three months?

  • December 2025: 28.57% Strong Buy, 64.29% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 30.77% Strong Buy, 61.54% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 25.00% Strong Buy, 58.33% Buy, 8.33% Hold, 0% Sell, 8.33% Strong Sell.

What is Xencor’s EPS forecast?

Xencor's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.1, marking a -13.41% decrease from the reported $-3.58 in 2024. Estimates for the following years are $-2.75 in 2026, $-1.58 in 2027, and $-2.35 in 2028.

What is Xencor’s revenue forecast?

Xencor's average annual revenue forecast for its fiscal year ending in December 2025 is $113.93M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $163.51M, followed by $221.98M for 2027, and $236.72M for 2028.

What is Xencor’s net income forecast?

Xencor's net income forecast for the fiscal year ending in December 2025 stands at $-204M, representing a -12.11% decrease from the reported $-233M in 2024. Projections indicate $-190M in 2026, $-73.713M in 2027, and $-142M in 2028.